| 1 | Approve Financial Statements | For |
| 2 | Approve the Remuneration Report | Oppose |
| 3 | Approve Non-Financial Statements | For |
| 4 | Discharge of the Board of Directors and the Group Management | For |
| 5 | Approve the Dividend - CHF 1,800 per registered share and CHF 180 per participation certificate | For |
| 6 | Reduction of the share and participation capital | For |
| 7.1.1 | Re-elect Ernst Tanner - Chair (Executive) | Oppose |
| 7.1.2 | Re-elect Dieter Weisskopf - Vice Chair (Non Executive) | Oppose |
| 7.1.3 | Re-elect Dr. Rudolf K. Sprüngli - Non-Executive Director | Oppose |
| 7.1.4 | Re-elect Elisabeth Gürtler - Non-Executive Director | Oppose |
| 7.1.5 | Re-elect Thomas Rinderknecht - Non-Executive Director | Oppose |
| 7.1.6 | Re-elect Silvio Denz - Non-Executive Director | For |
| 7.1.7 | Re-elect Monique Bourquin - Non-Executive Director | Oppose |
| 7.1.8 | Elect Ricarda Demarmels - Non-Executive Director | For |
| 7.2.1 | Elect Compensation & Nomination Committee Member Monique Bourquin | Oppose |
| 7.2.2 | Elect Compensation & Nomination Committee Member Rudolf K. Sprüngli | Oppose |
| 7.2.3 | Elect Compensation & Nomination Committee Member Silvio Denz | For |
| 7.3 | Appoint Independent Proxy - Dr. Patrick Schleiffer | For |
| 7.4 | Appoint the Auditors | Oppose |
| 8.1 | Approve Fees Payable to the Board of Directors | For |
| 8.2 | Approval of the maximum aggregate compensation amount for the Group Management for the financial year 2027 | Oppose |
| 22 | Transact Any Other Business | Oppose |
